Rationale and design of the long-Term rIsk, clinical manaGement, and healthcare Resource utilization of stable coronary artery dISease in post-myocardial infarction patients (TIGRIS) study (2017)
- Authors:
- Autor USP: NICOLAU, JOSÉ CARLOS - FM
- Unidade: FM
- DOI: 10.1002/clc.22837
- Subjects: VASOS CORONÁRIOS; INFARTO DO MIOCÁRDIO; ASSISTÊNCIA À SAÚDE
- Language: Inglês
- Imprenta:
- Source:
- Título: Clinical cardiology
- ISSN: 0160-9289
- Volume/Número/Paginação/Ano: v. 40, n. 12, p. 1197-1204, 2017
- Este periódico é de assinatura
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: bronze
-
ABNT
WESTERMANN, Dirk e NICOLAU, José Carlos. Rationale and design of the long-Term rIsk, clinical manaGement, and healthcare Resource utilization of stable coronary artery dISease in post-myocardial infarction patients (TIGRIS) study. Clinical cardiology, v. 40, n. 12, p. 1197-1204, 2017Tradução . . Disponível em: https://doi.org/10.1002/clc.22837. Acesso em: 09 out. 2024. -
APA
Westermann, D., & Nicolau, J. C. (2017). Rationale and design of the long-Term rIsk, clinical manaGement, and healthcare Resource utilization of stable coronary artery dISease in post-myocardial infarction patients (TIGRIS) study. Clinical cardiology, 40( 12), 1197-1204. doi:10.1002/clc.22837 -
NLM
Westermann D, Nicolau JC. Rationale and design of the long-Term rIsk, clinical manaGement, and healthcare Resource utilization of stable coronary artery dISease in post-myocardial infarction patients (TIGRIS) study [Internet]. Clinical cardiology. 2017 ; 40( 12): 1197-1204.[citado 2024 out. 09 ] Available from: https://doi.org/10.1002/clc.22837 -
Vancouver
Westermann D, Nicolau JC. Rationale and design of the long-Term rIsk, clinical manaGement, and healthcare Resource utilization of stable coronary artery dISease in post-myocardial infarction patients (TIGRIS) study [Internet]. Clinical cardiology. 2017 ; 40( 12): 1197-1204.[citado 2024 out. 09 ] Available from: https://doi.org/10.1002/clc.22837 - Ticagrelor versus clopidogrel in patients with STEMI treated with fibrinolysis TREAT trial
- Ticagrelor vs Clopidogrel After Fibrinolytic Therapy in Patients With ST-Elevation Myocardial Infarction: A Randomized Clinical Trial (vol 3, pg 391, 2018)
- Effects of Dapagliflozin on Symptoms, Function, and Quality of Life in Patients With Heart Failure and Reduced Ejection Fraction Results From the DAPA-HF Trial
- Efficacy and Safety of Dapagliflozin in Heart Failure With Reduced Ejection Fraction According to Age Insights From DAPA-HF
- Effect of alirocumab on mortality after acute coronary syndromes an analysis of the ODYSSEY OUTCOMES randomized clinical trial
- Predicting risk of cardiovascular events 1 to 3 years post-myocardial infarction using a global registry
- Long-term ticagrelor for secondary prevention in patients with prior myocardial infarction and no history of coronary stenting: insights from PEGASUS-TIMI 54
- Two-year outcomes among stable high-risk patients following acute MI. Insights from a global registry in 25 countries
- Anti-Thrombotic Therapy to Ameliorate Complications of COVID-19 (ATTACC): Study design and methodology for an international, adaptive Bayesian randomized controlled trial
- Anticoagulação e antiagregação plaquetária nas síndromes isquêmicas miocárdicas instáveis [Carta]
Informações sobre o DOI: 10.1002/clc.22837 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
